Video
Innovations in Dermatology: Brodalumab for Plaque Psoriasis
- Author:
- Lawrence J. Green
Publish date: October 10, 2017
In February 2017, the US Food and Drug Administration approved injectable brodalumab (210 mg) to treat patients with moderate to severe plaque...